U.S. markets open in 1 hour 21 minutes

Stereotaxis, Inc. (STXS)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
9.13+0.02 (+0.22%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Long-term KST

Long-term KST

Previous Close9.11
Open9.16
Bid8.06 x 1000
Ask0.00 x 800
Day's Range9.06 - 9.32
52 Week Range3.03 - 10.30
Volume176,060
Avg. Volume445,304
Market Cap676.661M
Beta (5Y Monthly)1.55
PE Ratio (TTM)N/A
EPS (TTM)-0.10
Earnings DateAug 10, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est10.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Stereotaxis Strengthens Board of Directors with Appointment of Myriam J. Curet, M.D.
    GlobeNewswire

    Stereotaxis Strengthens Board of Directors with Appointment of Myriam J. Curet, M.D.

    ST. LOUIS, July 26, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced the appointment of Myriam J. Curet, M.D., to its Board of Directors. Dr. Curet currently serves as Executive Vice President and Chief Medical Officer for Intuitive Surgical, the global leader and pioneer of robotic surgery. Dr. Curet joined Intuitive Surgical in 2005 and has since led the development of clinical evid

  • Stereotaxis to Report Second Quarter 2021 Financial Results on August 10, 2021
    GlobeNewswire

    Stereotaxis to Report Second Quarter 2021 Financial Results on August 10, 2021

    ST. LOUIS, July 20, 2021 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will release financial results for its 2021 second quarter on Tuesday, August 10, 2021 before the open of the U.S. financial markets. The Company will host a conference call and webcast at 10 a.m. EST that day to discuss the Company’s results and corporate developments. What:Stereotaxis second quarter 2021 fi

  • Here's Why "Trend" Investors Would Love Betting on Stereotaxis Inc. (STXS)
    Zacks

    Here's Why "Trend" Investors Would Love Betting on Stereotaxis Inc. (STXS)

    If you are looking for stocks that are well positioned to maintain their recent uptrend, Stereotaxis Inc. (STXS) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.